Sino Biopharmaceutical
$5.58Change from previous close: −2.28%Absolute change: −$0.13
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $99.38B
- Enterprise value
- $102.82B
- P/E (trailing 12 months)
- 37.2
- Forward P/E
- 18.3
- PEG
- 0.72
- Price/book
- 2.61
- Price/sales
- 2.95
- EV/EBITDA
- 9.84
- EV/revenue
- 3.05
Profitability and growth
- Gross margin
- 82.4%
- Operating margin
- 34.0%
- Net margin
- 7.1%
- ROE
- 14.1%
- ROA
- 7.5%
- Revenue growth (year over year)
- 10.6%
- Earnings growth (year over year)
- 1.5%
Financial health
- Total cash
- $27.58B
- Total debt
- $17.17B
- Debt/equity
- 0.37
- Current ratio
- 1.63
- Quick ratio
- 1.43
Dividends
- Annual dividend per share
- $0.14
- Dividend yield
- 2.5%
- Payout ratio
- 67.3%
- Ex-dividend date
- September 1, 2026
Analysts and estimates
- Average price target
- $8.44
- Median price target
- $8.69
- High price target
- $10.91
- Low price target
- $5.91
- Analysts with a price target
- 24
- Consensus
- Strong buy
- Forward EPS
- $0.31
- EPS estimate, current year
- $0.26
Shares and trading
- Beta
- 0.63
- Average volume
- 93.46M
- Shares outstanding
- 17.81B
- Float
- 8.73B
- Institutional ownership
- 23.5%
- Insider ownership
- 48.7%